Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Catherine Pachuk"'
Publikováno v:
Journal of Lipid Research, Vol 52, Iss 6, Pp 1265-1271 (2011)
Apolipoprotein CIII (apoCIII), a major constituent of triglyceride-rich lipoprotein, has been proposed as a key contributor to hypertriglyceridemia on the basis of its inhibitory effects on lipoprotein lipase. Many immunochemical methods have been de
Externí odkaz:
https://doaj.org/article/aab0bf7dbe6d4441be42eb8ba450d9e8
Publikováno v:
Antiviral therapy. 16(4)
Background RNA interference (RNAi) provides an attractive tool to modulate biological systems, and ultimately, to treat human diseases. We describe early results from a Phase Ib, first-in-human safety and tolerability study of an RNAi-based therapy,
Publikováno v:
Journal of Lipid Research, Vol 52, Iss 6, Pp 1265-1271 (2011)
Apolipoprotein CIII (apoCIII), a major constituent of triglyceride-rich lipoprotein, has been proposed as a key contributor to hypertriglyceridemia on the basis of its inhibitory effects on lipoprotein lipase. Many immunochemical methods have been de
Autor:
Ashwin Gollerkeri, Shilu Wu, Catherine Pachuk, Baisong Liao, De-Min Zhu, Chunrong Wang, Debra Kellner, Marion Molina
Publikováno v:
Cancer Research. 71:1646-1646
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and its incidence continues to increase. Although there are approved therapies for HCC, the prognosis remains poor. The 5-year survival rate is < 5%. Nucleic acid-based therapeu